Roche Holding AG said U.S. regulators have widened the approved use of rheumatoid arthritis drug Actemra to include patients typically in earlier stages of treatment for the joint disease
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment